ATP (Apple Tree Partners) on LinkedIn: Aulos Bioscience Raises $20 ...

We are excited to share that Aulos Bioscience has raised $20 million in Series A extension funding from ATP (Apple Tree Partners), which will advance AU-007 through its Phase 2 …


Install CouponFollow Chrome Extension   CouponFollow Extension

$20
OFF

ATP (Apple Tree Partners) On LinkedIn: Aulos Bioscience Raises $20 ...

1 week from now

We are excited to share that Aulos Bioscience has raised $20 million in Series A extension funding from ATP (Apple Tree Partners), which will advance AU-007 through its Phase 2 …

linkedin.com

$20
OFF

Apple Tree Partners | Aulos Bioscience Raises $20 Mill...

1 week from now

Aug 1, 2023  · LARKSPUR, Calif.--(BUSINESS WIRE)--Aulos Bioscience, an immuno-oncology company working to revolutionize cancer care through the development of potentially best-in …

appletreepartners.com

$20
OFF

Aulos Bioscience Raises $20 Million In Series A Extension Financing ...

1 week from now

LARKSPUR, Calif., August 1, 2023 – Aulos Bioscience, an immuno-oncology company working to revolutionize cancer care through the development of potentially best-in-class IL-2 …

aulosbio.com

$20
OFF

Aulos Bioscience Raises $20 Million In Series A Extension Financing ...

1 week from now

Aug 1, 2023  · Aulos Bioscience Raises $20 Million in Series A Extension Financing From Apple Tree Partners. Funds from ATP will continue to sustain the progress of Aulos’ novel IL-2 …

businesswire.com

$20
OFF

Aulos Bioscience Raises $20M In Series A Extension Financing

1 week from now

Aug 1, 2023  · Aulos Bioscience, a Larkspur, CA-based immuno-oncology company, raised $20m in Series A extension funding.. Apple Tree Partners (ATP) made the investment. The company …

finsmes.com

$20
OFF

Melanie Lorraine O. On LinkedIn: Aulos Bioscience Raises $20 …

1 week from now

We are excited to share that Aulos Bioscience has raised $20 million in Series A extension funding from ATP (Apple Tree Partners), which will advance AU-007 through its Phase 2 …

linkedin.com

$20
OFF

Aulos Bioscience Raises $20 Million In Series A Extension

1 week from now

Aug 1, 2023  · Aulos Bioscience, an immuno-oncology company working to revolutionize cancer care through the development of potentially best-in-class IL-2 therapeutics, today announced …

biospace.com

$20
OFF

Aulos Bioscience Raises $20 Million In Series A Extension Financing ...

1 week from now

LARKSPUR, Calif., August 01, 2023--Aulos Bioscience, an immuno-oncology company working to revolutionize cancer care through the development of potentially best-in-class IL-2 …

yahoo.com

$20
OFF

News - Apple Tree Partners

1 week from now

Oct 30, 2024  · Aug 01, 2023 Aulos Bioscience Raises $20 Million in Series A Extension Financing From Apple Tree Partners Jul 11, 2023 Apple Tree Partners Recruits Noted Biotech …

appletreepartners.com

$20
OFF

Aulos Bioscience Raises $20 Million In Series A Extension

1 week from now

Aug 1, 2023  · LARKSPUR, Calif.--(BUSINESS WIRE)-- Aulos Bioscience, an immuno-oncology company working to revolutionize cancer care through the development of potentially best-in …

biospace.com

$20
OFF

Aulos Bioscience Raises $20 Million In Series A Extension Financing ...

1 week from now

On August 1, 2023 Aulos Bioscience, an immuno-oncology company working to revolutionize cancer care through the development of potentially best-in-class IL-2 therapeutics, reported …

1stoncology.com

FAQs about ATP (Apple Tree Partners) on LinkedIn: Aulos Bioscience Raises $20 ... Coupon?

What is Aulos Bioscience presenting at ASCO24?

At ASCO24, our portfolio company Aulos Bioscience will be presenting promising interim clinical data from its lead program AU-007, an anti-cancer therapeutic. Discover the positive interim results from their Phase 1/2 trial being presented at #ASCO24. ...

What is aulos Bioscience presenting at 2023 AACR-NCI-EORTC?

Aulos Bioscience is presenting encouraging pharmacodynamic data for AU-007 from Phase 1 dose escalation cohorts at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics on Oct 04. ...

Does aulos Bioscience's au-007 show pharmacodynamic effects at 2023 AACR-NCI-E?

New Phase 1 Dose Escalation Cohorts Data for Aulos Bioscience’s au-007 showed favorable pharmacodynamic effects at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics. ...

Install CouponFollow Extension on Chrome

Install the CouponFollow extension to search for discount codes when shopping the fastest!

Install CouponFollow Chrome Extension   Install CouponFollow Chrome Extension